<DOC>
	<DOCNO>NCT03047486</DOCNO>
	<brief_summary>The reference treatment type 1 diabetes intensified insulin therapy insulin pump . The CGM ( continuous glucose monitor ) technology available decade , allow continuous measure interstitial glucose rate . The result available real time user , use optimize adjustment treatment insulin pump . Since year , several research program aim finalize automate system use data real time interstitial glucose adjust automatically , via algorithm , release insulin pump . This type closed-loop system moment experimental , still widely available routine . On hand , rudimentary regulation system partially automate already exist used common clinical practice . One system , Smartguard ® , allow type regulation decrease hypoglycemic risk patient treat insulin pump . It indeed hypo minimizer interrupt basal output algorithm embark pump determines thanks CGM data hypoglycemia risk occur 30 minute . The efficiency system reduce hypoglycemia prove several study pediatric adult population subject DT1 ( Diabetes Care 2015 ; 38:1197-1204 . J Diabetes Sci Technol . 2016 May 20 . Pii : 1932296816645119 ) . However , date , publish data concern method use system ( sensor et pump initial configuration ; patient education ) , evolution sensor pump parameter use . The aim observationnelle study collect data efficiency , safety use system Smartguard ® common clinical practice adult population subject DT1 .</brief_summary>
	<brief_title>Smartguard Use Real Life : Longitudinal Study Patients With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Type 1 diabetes ≥ 1 year CSII ≥ 6 month Previous education flexible insulin therapy Patient willing use sensor smartguard option 1 year A1c ≥ 7.5 % and/or severe hypoglycemia ≥ 2 episode last 6 month and/or recurrent hypoglycemia and/or hypoglycemia unawareness and/or brittle diabetes No access computer and/or web make impossible follow patient telemedicine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>insulin pump</keyword>
	<keyword>continuous glucose monitoring sensor</keyword>
	<keyword>predictive low glucose suspend</keyword>
</DOC>